AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 81 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2022. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $469,536 | -37.5% | 45,586 | 0.0% | 0.10% | +35.7% |
Q2 2023 | $751,257 | +929.1% | 45,586 | +52.0% | 0.07% | +1066.7% |
Q2 2022 | $73,000 | -91.6% | 30,000 | -72.2% | 0.01% | -88.7% |
Q4 2021 | $873,000 | +52.4% | 108,079 | +84.7% | 0.05% | +211.8% |
Q3 2021 | $573,000 | -63.2% | 58,501 | -74.7% | 0.02% | -37.0% |
Q2 2021 | $1,555,000 | -29.5% | 231,073 | -5.3% | 0.03% | -28.9% |
Q1 2021 | $2,206,000 | -4.5% | 244,068 | -29.4% | 0.04% | -9.5% |
Q4 2020 | $2,310,000 | +188.0% | 345,767 | +117.2% | 0.04% | +133.3% |
Q3 2020 | $802,000 | -37.6% | 159,200 | 0.0% | 0.02% | -35.7% |
Q2 2020 | $1,286,000 | -42.2% | 159,200 | -43.2% | 0.03% | -49.1% |
Q1 2020 | $2,224,000 | -5.1% | 280,200 | -9.7% | 0.06% | +44.7% |
Q4 2019 | $2,344,000 | – | 310,469 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |